Skip to Main Content

Paper Details

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS.
Frontiers in Neurology
11
2022
DMT, DMTS, LOMS, MS, Multiple sclerosis, inflammatory demyelinating and neurodegenerative disease of the, motor disability, patients
Author NameAffiliation
Marco SalvettiSapienza University
Marco SalvettiIRCCS Istituto Neurologico Mediterraneo (INM) Neuromed
  • 1 - 2

Datasets

Release 1.2